A novel osteoblast-derived molecule that inhibits the early phase of osteoclast formation.
Vicky Kartsogiannis(Monash Institute of Medical Research), Hong Zhou(California NanoSystems Institute), Matthew T. Gillespie(Hudson Institute of Medical Research), Jan Elliott(St George's Hospital), TJ Martin, J Quinn(The University of Melbourne), KW Ng(St Vincents Institute of Medical Research), YS Hu(St Vincents Institute of Medical Research)
Cited by 1
Related Papers
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
|Endocrine Reviews|1999|2.3k
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
|Journal of Clinical Investigation|1999|1.7k
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
|Endocrinology|1999|536
Osteotropic Agents Regulate the Expression of Osteoclast Differentiation Factor and Osteoprotegerin in Osteoblastic Stromal Cells
|Endocrinology|1998|452
Activated T Lymphocytes Support Osteoclast Formation in Vitro
|Biochemical and Biophysical Research Communications|1999|425